Discovery could protect high-risk COVID-19 patients
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
Mar 13, 2023
0
35
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
Mar 13, 2023
0
35
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune ...
Mar 6, 2023
0
98
Patients with serious pneumococcal infections, including pneumonia and sepsis, are at a substantially increased risk of heart attack after the onset of infection according to a Vanderbilt study published in Clinical Infectious ...
Mar 2, 2023
0
20
The international group of scientists who successfully lobbied the World Health Organization to recognize the airborne transmission of COVID-19 have published four key steps needed to avoid similar critical mistakes in the ...
Feb 28, 2023
0
5
Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, and circulating variants ...
Feb 21, 2023
0
10
Scientists from the University of St Andrews reveal a new tuberculosis (TB) therapeutics that could shorten the treatment of the disease by up to two months, potentially saving millions of lives.
Feb 21, 2023
0
19
The latest published study from INSPIRE provides important new insight into how lingering symptoms differ by virus variant and more specific data about persistent fatigue—the symptom most associated with what has become ...
Feb 20, 2023
0
17
In a new study from INSPIRE (Innovative Support for Patients with SARS-CoV-2 Infections Registry), researchers compared new and ongoing symptoms and outcomes in both COVID-positive and COVID-negative adults who were tested ...
Feb 1, 2023
0
28
Three types of fungi that cause serious lung infections and were once thought to be confined to certain regions of the United States are now widespread.
Jan 5, 2023
0
18
Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication ...
Oct 21, 2022
0
54